Regions : Global

Nobel prize in physiology or medicine 2019
400 clinics in 22 countries
Diaverum responds to COVID-19
A message to our patients
Nobel prize in physiology or medicine 2019
A message to our employees
COVID-19 contingency plan
New Chief People and Communications Officer
Empowering patients to choose their dialysis type
d.ACADEMY re-accredited by EDTNA/ERCA
Krisja Vermeylen joins Board of Directors
Analysing and improving patient safety
A message from our CEO
Diaverum enters Singapore and Malaysia
Incidence and severity of COVID-19 in CKD patients
The leading independent renal care provider in Spain
Boris Zjacic steps down as Diaverum’s COO
IWD21 and Diaverum
Diaverum partners with WKD 2021
Diaverum’s Sustainability Report 2020
IND 2021: A Voice to Lead - A vision for future healthcare
Diaverum acquires
Living well with kidney disease
A milestone in our fight against COVID-19
June 2021- Pride in Diaverum
A partnership to ensure renal patients’ ability to travel
COVID-19: helping you to travel safely
Patient story: Joanna Bernet
Diaverum launches 2021 dialysis travel guide
Diaverum becomes an EPiHC signatory
Diaverum opens new clinic in NW England
Diaverum at the 49th EDTNA/ERCA conference
Acquisition of the 27th clinic in Portugal
We’re welcoming the first staff to our new HQ
Diaverum ExCo members key participants at HBI Conference
Health Literacy webinar
Gold website at the Corporate and Financial Awards 2021
Our latest breakthrough AI innovation
Diaverum Head Nurse elected to EDTNA ExCo
Diaverum's breakthrough VA AI model for thrombosis prevention
Diaverum expands in Brazil
HR System Project of the Year 2021 - finalist
Diaverum wins Gold at Digital Impact Awards
Turning the tables on COVID-19 through vaccination
Diaverum continues to grow in Chile with three new clinics
Year-end reflections and wishes
Diaverum Portugal celebrates launch of 29th clinic